MR Imaging Findings in Children with Merosin-Deficient Congenital Muscular Dystrophy

References

1. ↵
   Tome FM, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 1994;317:351-357

   PubMed
2. ↵
   Leyten QH, Gabreels FJ, Renier WO, et al. White matter abnormalities in congenital muscular dystrophy. J Neurol Sci 1995;129:162-169

   CrossRefPubMedWeb of Science
3. ↵
   Trevisan CP, Martinello F, Ferruzza E, Angelini C. Divergence of central nervous system involvement in 2 Italian sisters with congenital muscular dystrophy: a clinical and neuroradiological follow-up. Eur Neurol 1995;35:230-235

   PubMedWeb of Science
4. ↵
   Trevisan CP, Carollo C, Segalla P, Angelini C, Drigo P, Giordano R. Congenital muscular dystrophy: brain alterations in an unselected series of Western patients. J Neurol Neurosurg Psychiatry 1991;54:330-334

   Abstract/FREE Full Text
5. Aida N, Tamagawa K, Takada K, et al. Brain MRI in Fukuyama congenital muscular dystrophy. AJNR Am J Neuroradiol 1996;17:605-613

   Abstract
6. ↵
   Mercuri E, Muntoni F, Berardinelli A, et al. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status. Neuropediatrics 1995;26:3-7

   PubMedWeb of Science
7. Reed UC, Marie SK, Vainzof M, et al. Congenital muscular dystrophy with cerebral white matter hypodensity: correlation of clinical features and merosin deficiency. Brain Dev 1996;18:53-58

   CrossRefPubMedWeb of Science
8. Nogen AG. Congenital muscle disease and abnormal findings on computerized tomography. Dev Med Child Neurol 1980;22:658-663

   PubMed
9. Yoshioka M, Kuroki S, Mizue H. Congenital muscular dystrophy of non-Fukuyama type with characteristic CT images. Brain Dev 1987;9:316-318

   PubMedWeb of Science
10. ↵
    Trevisan CP, Martinello F, Ferruzza E, Fanin M, Chevallay M, Tome FM. Brain alterations in the classical form of congenital muscular dystrophy: clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle. Childs Nerv Syst 1996;12:604-610

    PubMedWeb of Science
11. ↵
    Engvall E, Davis GE, Dickerson K, Ruoslahti E, Varon S, Manthorpe M. Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site. J Cell Biol 1986;103:2457-2465

    Abstract/FREE Full Text
12. Vuolteenaho R, Nissinen M, Sainio K, et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 1994;124:381-394

    Abstract/FREE Full Text
13. ↵
    Pegoraro E, Mancias P, Swerdlow SH, et al. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy. Ann Neurol 1996;40:782-791

    CrossRefPubMedWeb of Science
14. Engvall E, Earwicker D, Day A, Muir D, Manthorpe M, Paulsson M. Merosin promotes cell attachment and neurite outgrowth and is a component of the neurite-promoting factor of RN22 schwannoma cells. Exp Cell Res 1992;198:115-123

    CrossRefPubMedWeb of Science
15. Tan E, Topaloglu H, Sewry C, et al. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromuscul Disord 1997;7:85-89

    CrossRefPubMedWeb of Science
16. ↵
    Villanova M, Malandrini A, Toti PE, et al. Localization of merosin in the normal human brain: implications for congenital muscular dystrophy with merosin deficiency. J Submicrosc Cytol Pathol 1996;28:1-4

    PubMedWeb of Science
17. Leyten QH, Gabreels FJM, Renier WO, et al. White matter abnormalities in congenital muscular dystrophy. J Neurol Sci 1995;129:162-169
18. ↵
    Hall JA. Neurodiagnosis: central nervous system. Handbook of Auditory Evoked Responses Boston: Allyn & Bacon; 1992;419-472